Escherichia coli Infections: all 100 studies

Page 1 of 1. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• Randomized, Multicenter, Non-inferiority Trial Comparing the Efficacy of Fosfomycin Versus Fluoroquinolones or Cotrimoxazole as Oral Follow-up Treatment in Febrile Urinary Tract Infections in Men Caused by Susceptible EnterobacteriaNot yet recruitingNCT07932158Phase 3
• Fosfomycin Trometamol Compared With an Alternative Active Antibiotic as Step-down Therapy for the Treatment of Acute Pyelonephritis Due to Escherichia Coli in Elderly Women : a Randomized, Multicenter, Non-inferiority TrialNot yet recruitingNCT07928063Phase 3
• Comparative Study of the Genomic Characteristics of Uropathogenic Escherichia Coli According to the Severity of Community-Acquired Urinary Tract Infections in Guadeloupe (COLIGENURI)Not yet recruitingNCT07905638
• Genomic and Phenotypic Diversity of Carbapenemase-producing Escherichia Coli Strains Circulating in Southern FranceNot yet recruitingNCT07676513
• Cefotetan Therapy for Escherichia Coli InfectionsRecruitingNCT07318584Phase 2
• Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung InfectionsNot yet recruitingNCT07280598Phase 1
• Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of CareRecruitingNCT07236944Phase 4
• Extended Tricyle Project Indonesia for Extended-spectrum Beta-lactamase Positive Klebsiella Pneumoniae and Escherichia ColiNot yet recruitingNCT07106944
• Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-TransplantRecruitingNCT06938867Phase 1/2
• An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"Not yet recruitingNCT06815549Phase 3
• A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of AgeRecruitingNCT06702449Phase 1/2
• Bacteriophage Therapy in Spinal Cord Injury Patients With BacteriuriaRecruitingNCT06559618Phase 1
• Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli)RecruitingNCT06314880Phase 1
• Gram-Negative Bloodstream Infection Oral Antibiotic Therapy TrialRecruitingNCT06080698Not applicable
• Impact of Reducing Colistin Use on Colistin Resistance in Humans and Poultry in IndonesiaNot yet recruitingNCT05960084
• Clinical Outcomes in Patients With Infection by Resistant MicroorganismEnrolling by invitationNCT05880069
• Study of E. Coli Isolates From Recurrent Urinary Tract InfectionsRecruitingNCT05826067
• A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)RecruitingNCT05488340Phase 2
• Hyperhydration in Children With Shiga Toxin-Producing E. Coli InfectionRecruitingNCT05219110Not applicable
• Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal FloraRecruitingNCT05153824
• NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant BacteriaRecruitingNCT05017766
• Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of TreatmentRecruitingNCT04846803Not applicable
• Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract InfectionsCompletedNCT05138822Phase 1Results posted
• A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic AreaTerminatedNCT03548064Phase 1Results posted
• Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)CompletedNCT03404674Phase 1Results posted
• Efficacy of B7A BSIgG Against E. Coli Strain B7A ChallengeCompletedNCT03040687Phase 1Results posted
• Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7ACompletedNCT02773446Not applicableResults posted
• Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in BangladeshCompletedNCT02531802Phase 1/2Results posted
• Safety Study of Chimeric Vaccine to Prevent ETEC DiarrheaCompletedNCT01644565Phase 1Results posted
• The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children"CompletedNCT01595529Phase 2Results posted
• Rifaximin for Prevention of Travellers' DiarrheaCompletedNCT00742469Phase 3Results posted
• Cranberry for UTI Prevention in Residents of Long Term Care FacilitiesCompletedNCT00596635Not applicableResults posted
• Bacterial Interference for Prevention of Catheter-Associated UTI: Geriatric Pilot StudyCompletedNCT00554996Phase 1Results posted
• Colonizing Neurogenic Bladders With Benign FloraCompletedNCT00371631Phase 1Results posted
• Oral Fosfomycin as Sequential Oral Treatment for Multidrug-Resistant Escherichia Coli in Acute Bacterial ProstatitisCompletedNCT07902427Phase 4
• Meatsafe Food Storage and Diarrhea Prevention Trial in Urban BangladeshCompletedNCT07332078Not applicable
• Health Impacts of Street Vended FruitsCompletedNCT06858046Not applicable
• Evaluation of the Prevalence of E. Coli O Serotypes in Paediatric Population With Recurrent Urinary Tract InfectionWithdrawnNCT06482151
• Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University HospitalsCompletedNCT06252428
• Perinatal Transmission of MDR BacteriaCompletedNCT06148480
• The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu VirusCompletedNCT05797103Not applicable
• Quinolone Resistance Profiles and Mechanisms of Staphylococcus Aureus and Escherichia Coli From Humans, Chicken and Catfish Farms in IndonesiaStatus unknownNCT05652556
• Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing BacteremiaTerminatedNCT05613322
• The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella VaccineStatus unknownNCT05279248Phase 4
• Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia ColiCompletedNCT04764500
• Egg Intervention During Pregnancy in IndonesiaActive, not recruitingNCT04694235Not applicable
• Cefuroxime Resistance in PyelonephritisCompletedNCT04616352
• Preventing Urinary Tract Infections With E. Coli Nissle:Status unknownNCT04608851Phase 4
• Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia ColiCompletedNCT04574596
• Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)CompletedNCT04117113
• Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)CompletedNCT04087681
• Efficacy of Intravenous Fosfomycin in the Treatment of Complicated Urinary in Real-life Conditions.Status unknownNCT04076436
• Immunomodulation Therapy for Urinary Tract InfectionsCompletedNCT04049994Phase 4
• Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing EnterobacteriaceaeSuspendedNCT03891433Phase 4
• Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus BacteriaTerminatedNCT03869593
• Effects of Nutritional Fat on the Growth of Intestinal E. ColiStatus unknownNCT03800147Not applicable
• Selective Reporting of Antibiotic Susceptibility Test Results in Urinary Tract Infections in the Outpatient SettingStatus unknownNCT03612297
• The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli InfectionCompletedNCT03596827Not applicable
• Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care PatientsCompletedNCT03303937
• PTM202 and Modulation of Host Resistance to Diarrheagenic E. ColiCompletedNCT03301103Not applicable
• Trial of Low-cost Microbiological Water Test KitsCompletedNCT03021434Not applicable
• Psychological Evaluation According Colonic Colonization by Escherichia Coli of Patients After Colorectal SurgeryCompletedNCT02970513Not applicable
• Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic ImplicationsCompletedNCT02890901
• Epidemiology of ST131 in Besançon University HospitalCompletedNCT02853708
• The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421CompletedNCT02847065
• Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation PatientsStatus unknownNCT02729116Phase 2/3
• Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. ColiCompletedNCT02541695Not applicable
• Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia ColiStatus unknownNCT02537847Phase 2
• Phase 1 Study of dmLT ID Vaccination in Healthy AdultsCompletedNCT02531685Phase 1
• Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASHCompletedNCT02390232
• Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU StaffStatus unknownNCT02367339
• Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.ColiCompletedNCT02142751Phase 3
• Safety of Sublingual dmLT for ETECCompletedNCT02052934Phase 1
• Challenge Study of an ETEC VaccineCompletedNCT01922856Phase 2
• Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia ColiTerminatedNCT01820793Not applicable
• Milk Ingredients and Resistance Against E-coli-induced GastroEnteritis (MIRAGE)CompletedNCT01800396Not applicable
• Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract InfectionsCompletedNCT01776021Not applicable
• Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4CompletedNCT01406288
• Safety Study of Recombinant Vaccine to Prevent ETEC DiarrheaCompletedNCT01382095Phase 1
• Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing OrganismsCompletedNCT01324726
• Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2CompletedNCT01252199Phase 2
• The Effect of Probiotics on E. Coli GastroenteritisCompletedNCT01225042Not applicable
• Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen RhinoconjunctivitisCompletedNCT01013259Phase 2
• Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate BiopsyCompletedNCT00915213
• Effect of Antioxidants on Oxygen Induced Vasoconstriction in Lipopolysaccharide (LPS) Induced Inflammatory Model in HumansCompletedNCT00914576Not applicable
• Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT ProtocolCompletedNCT00877708
• Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult SubjectsCompletedNCT00654108Phase 1
• Ampicillin-sulbactam Resistant E.Coli at UPMCWithdrawnNCT00619580
• ETEC Logistics Trial (TREK)CompletedNCT00516659Phase 2
• E. Coli for Prevention of Catheter UTI in SCI PatientsCompletedNCT00458471Phase 1
• Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.CompletedNCT00431691Phase 4
• Community - Associated Extended-spectrum Beta-lactamases (ESBL)CompletedNCT00363220
• Enteroaggregative E.Coli (EAEC)TerminatedNCT00362869Phase 1
• Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.CompletedNCT00328380Phase 3
• Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI)CompletedNCT00309114Not applicable
• Antibiotic Resistant Community-Acquired E. ColiCompletedNCT00298103
• Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology UnitsCompletedNCT00167999
• Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive CareCompletedNCT00167986
• Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate ResistanceCompletedNCT00137657Phase 4
• Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic SyndromeTerminatedNCT00004465Phase 3

← Escherichia coli Infections overview